The invention refers to the use of an engineered 'Clustered Regularly Interspersed Short Palindromic Repeat (CRISPR)-CRISPR associated (Cas)’ (CRISPR-Cas) technology targeting a sequence mutated at one or more loci in the genome of a given eukaryotic cell

Settore:

Life sciences

Research Institution:

Università degli Studi di Siena

Publication number:

WO2020127272A1

TRL:

3

Technologies, Systems, Applications:

Biotechnologies,
New drugs development

Technological Priority:

Biotechnologies for health,
Biomedical, pharmaceutical, pharmacological technologies
Pubblicato il:
Torna in cima alla pagina